Gaynor N, Blanco A, Madden SF, Moran B, et al. Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy. Br J Cancer 2023 Jul 28. doi: 10.1038/s41416-023-02375.
PMID: 37507543